STRATA Skin Sciences Confirms Nasdaq Delisting

STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of ...

STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis

The February 2026 meta-analysis confirms that 308 nm Excimer Laser therapy, reliably produces significant improvement in plaque psoriasis. STRATA Skin Sciences remains committed to advancing clinical ...

Strata Skin Sciences Down After Hours on Upcoming Nasdaq Delisting

Shares of Strata Skin Sciences fell 49% to 61 cents after hours as the medical technology company said shares will be suspended from Nasdaq Feb. 19. The company expects to file a Form 15 with the ...

Strata Critical Medical Schedules Fourth Quarter 2025 Earnings Conference Call

Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026 before the market opens. The ...
The Manila Times

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution

ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditionsOwned aircraft excluded from collateral package and remain ...

Body corporates urged to be cautious after alleged $2m strata account fraud

The loss of $2 million from strata property accounts on the NSW Mid North Coast triggers concerns about the protection of ...